Envestnet Asset Management Inc Cytokinetics Inc Transaction History

Envestnet Asset Management Inc

  • $299 Billion
  • Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 24,321 shares of CYTK stock, worth $803,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,321
Previous 26,455 8.07%
Holding current value
$803,565
Previous $1.24 Million 21.46%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
SELL
$40.19 - $51.12 $85,765 - $109,090
-2,134 Reduced 8.07%
24,321 $977,000
Q4 2024

Feb 12, 2025
SELL
$46.36 - $58.62 $306,532 - $387,595
-6,612 Reduced 20.0%
26,455 $1.24 Million
Q3 2024

Nov 06, 2024
BUY
$51.22 - $60.16 $125,028 - $146,850
2,441 Added 7.97%
33,067 $1.75 Million
Q2 2024

Aug 08, 2024
BUY
$47.86 - $75.05 $293,238 - $459,831
6,127 Added 25.01%
30,626 $1.66 Million
Q1 2024

May 13, 2024
BUY
$63.75 - $108.06 $238,552 - $404,360
3,742 Added 18.03%
24,499 $1.72 Million
Q4 2023

Feb 13, 2024
SELL
$26.88 - $83.49 $193,536 - $601,128
-7,200 Reduced 25.75%
20,757 $1.73 Million
Q3 2023

Nov 13, 2023
BUY
$29.46 - $36.61 $207,486 - $257,844
7,043 Added 33.68%
27,957 $823,000
Q2 2023

Aug 04, 2023
SELL
$32.62 - $40.75 $14,026 - $17,522
-430 Reduced 2.01%
20,914 $682,000
Q1 2023

May 11, 2023
BUY
$33.36 - $45.71 $2,401 - $3,291
72 Added 0.34%
21,344 $751,000
Q4 2022

Feb 07, 2023
SELL
$35.77 - $51.11 $85,812 - $122,612
-2,399 Reduced 10.13%
21,272 $974,000
Q3 2022

Nov 10, 2022
SELL
$38.54 - $54.52 $14,067 - $19,899
-365 Reduced 1.52%
23,671 $1.15 Million
Q2 2022

Aug 03, 2022
BUY
$33.93 - $48.92 $142,573 - $205,561
4,202 Added 21.19%
24,036 $944,000
Q1 2022

May 04, 2022
BUY
$29.74 - $46.0 $42,201 - $65,274
1,419 Added 7.71%
19,834 $730,000
Q4 2021

Feb 04, 2022
BUY
$34.35 - $46.38 $91,027 - $122,907
2,650 Added 16.81%
18,415 $839,000
Q3 2021

Oct 07, 2021
SELL
$18.54 - $35.74 $87,360 - $168,406
-4,712 Reduced 23.01%
15,765 $563,000
Q2 2021

Aug 04, 2021
BUY
$19.79 - $26.99 $33,247 - $45,343
1,680 Added 8.94%
20,477 $405,000
Q1 2021

May 04, 2021
BUY
$18.57 - $25.68 $128,133 - $177,192
6,900 Added 58.0%
18,797 $437,000
Q4 2020

Feb 02, 2021
SELL
$15.26 - $28.61 $26,582 - $49,838
-1,742 Reduced 12.77%
11,897 $247,000
Q3 2020

Oct 09, 2020
BUY
$20.58 - $28.96 $18,398 - $25,890
894 Added 7.01%
13,639 $295,000
Q2 2020

Jul 08, 2020
SELL
$11.15 - $24.64 $82,052 - $181,325
-7,359 Reduced 36.6%
12,745 $300,000
Q1 2020

Apr 23, 2020
BUY
$8.75 - $16.3 $175,910 - $327,695
20,104 New
20,104 $237,000

Others Institutions Holding CYTK

# of Institutions
408
Shares Held
127M
Call Options Held
3.66M
Put Options Held
900K
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.11B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email